These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 24884314

  • 21. [Characteristic and prognostic significance of leukemia stem cells associated antigens expressions in t (8;21) acute myeloid leukemia].
    Dao FT, Yang L, Wang YZ, Chang Y, Jiang Q, Jiang H, Liu YR, Huang XJ, Qin YZ.
    Zhonghua Xue Ye Xue Za Zhi; 2019 Oct 14; 40(10):831-836. PubMed ID: 31775482
    [Abstract] [Full Text] [Related]

  • 22. High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML).
    Wang L, Gao L, Xu S, Gong S, Liu M, Qiu H, Xu X, Ni X, Chen L, Lu S, Chen J, Song X, Zhang W, Yang J, Hu X, Wang J.
    Ann Hematol; 2014 Oct 14; 93(10):1685-94. PubMed ID: 24844781
    [Abstract] [Full Text] [Related]

  • 23. [In Vitro Identification and Characteristics of CD34- Leukemia Stem Cell in t(8;21) Acute Myeloid Leukemia].
    Zhang YH, Yang L, Wang YZ, Kong Y, Zhu HH, Qin YZ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct 14; 25(5):1289-1294. PubMed ID: 29070097
    [Abstract] [Full Text] [Related]

  • 24. Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia.
    Zeijlemaker W, Kelder A, Cloos J, Schuurhuis GJ.
    Curr Protoc Cytom; 2019 Dec 14; 91(1):e66. PubMed ID: 31763792
    [Abstract] [Full Text] [Related]

  • 25. Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells.
    Terstappen LW, Safford M, Unterhalt M, Könemann S, Zurlutter K, Piechotka K, Drescher M, Aul C, Büchner T, Hiddemann W.
    Leukemia; 1992 Oct 14; 6(10):993-1000. PubMed ID: 1383649
    [Abstract] [Full Text] [Related]

  • 26. The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells.
    van Rhenen A, van Dongen GA, Kelder A, Rombouts EJ, Feller N, Moshaver B, Stigter-van Walsum M, Zweegman S, Ossenkoppele GJ, Jan Schuurhuis G.
    Blood; 2007 Oct 01; 110(7):2659-66. PubMed ID: 17609428
    [Abstract] [Full Text] [Related]

  • 27. Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission.
    Feuring-Buske M, Haase D, Buske C, Hiddemann W, Wörmann B.
    Leukemia; 1999 Mar 01; 13(3):386-92. PubMed ID: 10086729
    [Abstract] [Full Text] [Related]

  • 28. The prognostic effect on childhood acute lymphoblastic leukemia of CD34+CD38- expressed in leukemia cells.
    Zhao J, Wang Y, Zhou M, Gao J, Yuan Y.
    Hematology; 2022 Dec 01; 27(1):706-713. PubMed ID: 35688455
    [Abstract] [Full Text] [Related]

  • 29. CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia.
    Palmieri R, Buccisano F, Arena V, Irno Consalvo MA, Piciocchi A, Maurillo L, DelPrincipe MI, Di Veroli A, Paterno G, Conti C, Fraboni D, Voso MT, Arcese W, Venditti A.
    Leuk Lymphoma; 2022 Apr 01; 63(4):996-1000. PubMed ID: 34806525
    [No Abstract] [Full Text] [Related]

  • 30. Prognostic Impact and Phenotype of Residual Acute Myeloid Leukemia Stem Cells.
    Jaddaoui S, Bencharef H, Lamchahab M, Quessar A, Oukkache B.
    Clin Lab; 2022 Jun 01; 68(6):. PubMed ID: 35704721
    [Abstract] [Full Text] [Related]

  • 31. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
    Nishioka C, Ikezoe T, Furihata M, Yang J, Serada S, Naka T, Nobumoto A, Kataoka S, Tsuda M, Udaka K, Yokoyama A.
    Int J Cancer; 2013 May 01; 132(9):2006-19. PubMed ID: 23055153
    [Abstract] [Full Text] [Related]

  • 32. Lower phosphorylation of p38 MAPK blocks the oxidative stress-induced senescence in myeloid leukemic CD34(+)CD38 (-) cells.
    Xiao Y, Zou P, Wang J, Song H, Zou J, Liu L.
    J Huazhong Univ Sci Technolog Med Sci; 2012 Jun 01; 32(3):328-333. PubMed ID: 22684553
    [Abstract] [Full Text] [Related]

  • 33. High ALDHdim-expressing CD34+CD38- cells in leukapheresed peripheral blood is a reliable guide for a successful leukemic xenograft model of acute myeloid leukemia.
    Lee JY, Park S, Han AR, Lim J, Min WS, Kim HJ.
    Oncol Rep; 2014 Oct 01; 32(4):1638-46. PubMed ID: 25069538
    [Abstract] [Full Text] [Related]

  • 34. Senescence effects of Angelica sinensis polysaccharides on human acute myelogenous leukemia stem and progenitor cells.
    Liu J, Xu CY, Cai SZ, Zhou Y, Li J, Jiang R, Wang YP.
    Asian Pac J Cancer Prev; 2014 Jan 01; 14(11):6549-56. PubMed ID: 24377566
    [Abstract] [Full Text] [Related]

  • 35. Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients.
    Hanekamp D, Denys B, Kaspers GJL, Te Marvelde JG, Schuurhuis GJ, De Haas V, De Moerloose B, de Bont ES, Zwaan CM, de Jong A, Depreter B, Lammens T, Philippé J, Cloos J, van der Velden VHJ.
    Br J Haematol; 2018 Nov 01; 183(3):512-516. PubMed ID: 29076143
    [No Abstract] [Full Text] [Related]

  • 36. An immunophenotypic pre-treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38 low blasts.
    Khan N, Freeman SD, Virgo P, Couzens S, Richardson P, Thomas I, Grech A, Vyas P, Grimwade D, Russell NH, Burnett AK, Hills RK.
    Br J Haematol; 2015 Jul 01; 170(1):80-4. PubMed ID: 25876768
    [Abstract] [Full Text] [Related]

  • 37. Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products.
    Park KU, Kim SH, Suh C, Kim S, Lee SJ, Park JS, Cho HJ, Kim KW, Lee K, Kim HJ, Park J, Joo Min Y, Kim JG, Kim T, Lee JH, Kim SB, Kim SW, Lee KH, Lee JS, Kim WK, Park CJ, Chi HS.
    Am J Hematol; 2001 May 01; 67(1):42-7. PubMed ID: 11279656
    [Abstract] [Full Text] [Related]

  • 38. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
    Mohammadi S, Ghaffari SH, Shaiegan M, Zarif MN, Nikbakht M, Akbari Birgani S, Alimoghadam K, Ghavamzadeh A.
    Life Sci; 2016 May 01; 152():190-8. PubMed ID: 27063991
    [Abstract] [Full Text] [Related]

  • 39. [Proportion of CD34(+)CD38(-) cell population in bone marrow of patients with de novo AML as prognostic factor of complete remission at first course of induction chemotherapy].
    Zhang CP, Wei H, Wang HJ, Huai L, He K, Chen YR, Lin D, Wang JX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct 01; 19(5):1268-72. PubMed ID: 22040986
    [Abstract] [Full Text] [Related]

  • 40. Identification of a leukemia-initiating stem cell in human mast cell leukemia.
    Eisenwort G, Sadovnik I, Schwaab J, Jawhar M, Keller A, Stefanzl G, Berger D, Blatt K, Hoermann G, Bilban M, Willmann M, Winding C, Sperr WR, Arock M, Rülicke T, Reiter A, Valent P.
    Leukemia; 2019 Nov 01; 33(11):2673-2684. PubMed ID: 30953030
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.